Average Co-Inventor Count = 4.32
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aventis Pharma S.a. (10 from 377 patents)
2. Sanofi-a Ventis Deutschland Gmbh (3 from 1,827 patents)
3. Sanofi (3 from 1,451 patents)
4. The Scripps Research Institute (2 from 1,186 patents)
5. Sanofi-aventis (2 from 389 patents)
6. Novexel (1 from 4 patents)
7. Novexel Sa (1 from 2 patents)
22 patents:
1. 10941139 - Cryptophycin compounds and conjugates, their preparation and their therapeutic use
2. 8865906 - Process for the preparation of a compound useful as an inhibitor of TAFIa
3. 8314244 - Method for preparing activated esters
4. 8207355 - Method for preparing azetidine derivatives
5. 8119813 - [object Object]
6. 7884123 - Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof
7. 7589117 - Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them
8. 7579366 - Epothilone derivatives and their synthesis and use
9. 7265111 - Adenosine analogues and their use as pharmaceutical agents
10. 7232833 - 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
11. 7232834 - Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
12. 7227022 - Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
13. 7078428 - Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them
14. 6953796 - Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
15. 6872740 - Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase